Relative bioavailability of a prototype oral solution of the Aurora A kinase inhibitor alisertib (MLN8237) in patients with advanced solid tumors

Gerald S. Falchook, Karthik Venkatakrishnan, John Sarantopoulos, Razelle Kurzrock, Alain C. Mita, Siqing Fu, Monica M. Mita, Xiaofei Zhou, Jung Ah Jung, Claudio Dansky Ullmann, Catherine Milch, Lee S. Rosen

Resultado de la investigación: Articlerevisión exhaustiva

7 Citas (Scopus)

Huella

Profundice en los temas de investigación de 'Relative bioavailability of a prototype oral solution of the Aurora A kinase inhibitor alisertib (MLN8237) in patients with advanced solid tumors'. En conjunto forman una huella única.

Chemistry

Pharmacology, Toxicology and Pharmaceutical Science

Biochemistry, Genetics and Molecular Biology

Medicine and Dentistry

Engineering